The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Parkinson’s Alert Dogs, a local non-profit, has recently released astonishing research. In 2016, PADs became the only program ...

(WDRB) -- Norton Healthcare's Neuroscience Institute will soon begin offering a non-invasive procedure to reduce tremors in Parkinson's patients ... Parkinson’s disease, according to a ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

The research team suggests that the treatment can help address very early stages of a condition such as Alzheimer’s or ...

Global Central Nervous System Therapeutics Market is valued at approximately USD 143.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period ...

Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics: Houston Tuesday, November 5, 2024, 11:00 ...

The average Montreal Cognitive Assessment (MoCA) score at screening was 19 in both groups, indicating mild to moderate ...